Microbiome-based therapeutics for ocular diseases

Area of Science:

• Microbiome research
• Ophthalmology
• Immunology

Background:

• The gut microbiome's role in systemic health is increasingly recognized.
• The gut-eye axis describes the bidirectional communication between the gut and the eyes.
• Ocular diseases like dry eye disease, uveitis, and glaucoma may be linked to gut dysbiosis.

Purpose of the Study:

• To review current evidence on the gut-eye axis and its impact on ocular health.
• To explore how gut microbiome alterations contribute to ocular disease mechanisms.
• To examine the therapeutic potential of targeting the gut microbiome for eye conditions.

Main Methods:

• Literature review of studies investigating the gut-eye axis.
• Analysis of research linking gut dysbiosis to immune dysregulation and inflammation.
• Synthesis of evidence on microbiome-targeted interventions for ocular diseases.

Main Results:

• Gut dysbiosis is associated with immune dysregulation, chronic inflammation, and barrier dysfunction, contributing to ocular pathology.
• Alterations in the gut microbiome can influence the development, progression, and severity of various eye diseases.
• Microbiome-targeted interventions show promise in restoring microbial balance and modulating immune responses.

Conclusions:

• The gut-eye axis is a significant factor in ocular health and disease.
• Understanding this axis opens avenues for novel therapeutic strategies.
• Microbiome modulation offers potential for managing and treating prevalent ocular conditions.